pentobarbital will lower the level or outcome of saxagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.

pentobarbital will decrease the extent or outcome of eletriptan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

pentobarbital will minimize the level or effect of levonorgestrel oral/ethinylestradiol/ferrous bisglycinate by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. The efficacy of hormonal contraceptives could possibly be diminished.

fentanyl intranasal and pentobarbital both equally improve sedation. Prevent or Use Alternate Drug. Restrict use to sufferers for whom choice therapy selections are insufficient

pentobarbital will lower the extent or impact of etravirine by impacting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Observe.

pentobarbital will reduce the extent or effect of iloperidone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

Contraindicated (1)pentobarbital will minimize the level or outcome of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with potent CYP3A4 inducers can result in lowered serum concentrations and loss of antimalarial efficacy

pentobarbital will lower the extent or effect of nelfinavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will minimize the extent or impact of zonisamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.

Aged or debilitated individuals may perhaps react to barbiturates with marked despair, exhilaration, and confusion; in a few patients, barbiturates consistently produce enjoyment in lieu of depression

fentanyl transdermal and pentobarbital both equally maximize sedation. Stay away from or Use Alternate Drug. Limit use to patients for whom option remedy possibilities are inadequate

pentobarbital will decrease the extent or result of eucalyptus by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unidentified.

Coadministration of zuranolone with other CNS depressants may possibly improve impairment of psychomotor efficiency or CNS depressant read more effects. If unavoidable, take into consideration dose reduction. .

pentobarbital will reduce the level or outcome of zaleplon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Not known.